SMS Pharmaceuticals Limited — Important, 27-03-2025: Updates

The Securities Allotment Committee of SMS Pharmaceuticals Limited has allotted 40,00,000 equity shares to two allottees following the exercise of warrants, resulting in a capital infusion of Rs. 38.10 Cr. The share allotment was executed at a rate of Rs. 95.25 per warrant, which constitutes 75% of the issue price previously established. This conversion increases the company's paid-up share capital to Rs. 88.65 Cr, divided into 8,86,52,030 equity shares. The allotment consists of shares from two allottees: Ramesh Babu Potluri (25,00,000 shares) and Potluri Infra Projects LLP (15,00,000 shares). This move reflects the ongoing capital restructuring within the company, which may boost liquidity and support future growth initiatives. Investors should monitor potential impacts on share performance and overall capital strategy moving forward.